Overview

Topical Application of Latanoprost in Diabetic Retinopathy

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Randomized double-blinded two-year intervention study with topical application of latanoprost or placebo eye drops in patients with diabetic retinopathy.
Phase:
Phase 4
Details
Lead Sponsor:
University of Aarhus
Collaborator:
Aarhus University Hospital
Treatments:
Latanoprost